Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymes

References

• Berrigan M. J., Marinello A. J., Paveic Z., Williams C. J., Struck R. F., Gurtoo H. L. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism. Cancer Research 1982; 42: 3688–3695
   PubMed Web of Science ®Google Scholar
• Chang T. K. H., Waxman D. J. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5α-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard. Cancer Research 1993; 53: 2490–2497
   PubMed Web of Science ®Google Scholar
• Chang T. K. H., Weber G. F., Crespi C. L., Waxman D. J. Differential activation of cyclophosphamide and isophosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Research 1993; 53: 5629–5637
   PubMed Web of Science ®Google Scholar
• Clarke L., Waxman D. J. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Research 1989; 49: 2344–2350
   PubMed Web of Science ®Google Scholar
• Colvin M., Hilton J. Pharmacology of cyclophosphamide and metabolites. Cancer Treatment Reports 1981; 65: 89–95
   PubMedGoogle Scholar
• Craig P., Murray M., Farrell G. Interferon suppresses the isoform-specific activities of hepatic cytochrome P450 in female rats. Biochemical Pharmacology 1992; 43: 908–910
   PubMed Web of Science ®Google Scholar
• Donelli M. G., Garattini S. Drug metabolism after repeated treatments with cytotoxic agents. European Journal of Cancer 1971; 7: 361–364
   PubMed Web of Science ®Google Scholar
• Favreau L. V., Schenkman J. B. Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozotocin-induced diabetes and during insulin treatment. Diabetes 1988; 35: 577–584
   Google Scholar
• Favreau L. V., Malchoff D. M., Mole J. E., Schenkman J. B. Responses to insulin by two forms of rat hepatic microsomal cytochrome P-450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetes. Journal of Biological Chemistry 1987; 262: 14319–14326
   PubMed Web of Science ®Google Scholar
• Funae Y., Imaoka S., Shimojo N. Purification and characterization of diabetes-inducible cytochrome P-450. Biochemistry International 1988; 16: 503–509
   PubMedGoogle Scholar
• Guengerich F. P. Enzymology of rat liver cytochromes P450. Mammalian Cytochromes P-450, F. P. Guengerich. CRC Press, Boca Raton 1987; 1–54
   Google Scholar
• Gurtoo H. L., Gessner T., Cullion P. Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations. Cancer Treatment Reports 1976; 60: 1285–1294
   PubMedGoogle Scholar
• Gurtoo H. L., Marinello A. J., Struck R. F., Paul B., Dahms R. P. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites. Journal of Biological Chemistry 1981; 256: 11691–11701
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Marinello A. J., Berrigan M. J., Bansal S. K., Paul B., Pavelic Z. P., Struck R. F. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide. Seminars in Oncology 1983; 10: 35–45
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Bansal S. K., Pavelic Z., Struck R. F. Effects of the induction of hepatic microsomal metabolism on the toxicity of cyclophosphamide. British Journal of Cancer 1985; 51: 67–75
   PubMedGoogle Scholar
• Hanukoglu I. Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. Journal of Steroidal Biochemistry and Molecular Biology 1992; 43: 779–804
   PubMed Web of Science ®Google Scholar
• Hohorst H. J., Draeger U., Peter G., Voelcker G. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): studies on reactions that control the alkylating and cytotoxic activity. Cancer Treatment Reports 1976; 60: 309–315
   PubMedGoogle Scholar
• Ings R. M. J. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 1990; 11: 1201–1231
   Google Scholar
• Kennedy J. A., Nicolson R., Welby M. L. The effects of oleic acid on the secretion of thyrotropin and growth hormone by cultured rat anterior pituitary cells. Journal of Endocrinology 1994; 143: 557–564
   PubMed Web of Science ®Google Scholar
• Kikkawa Y. Diverse role of pulmonary cytochrome P-450 monoxygenase. Laboratory Investigation 1992; 67: 535–539
   PubMed Web of Science ®Google Scholar
• Ko I. Y., Park S. S., Song B. J., Patten C., Tan Y., Hah Y. C., Yang C. S., Gelboin H. V. Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolises aniline and nitrosamines. Cancer Research 1987; 47: 3101–3109
   PubMed Web of Science ®Google Scholar
• Lear L, Nation R. L., Stupans I. Influence of morphine concentration on detergent activation of rat liver morphine-UDP-glucuronosyltransferase. Biochemical Pharmacology 1991; 42: S55–60
   PubMedGoogle Scholar
• Le Blanc G. A., Waxman D. J. Mechanisms of cyclophosphamide action of hepatic P-450 expression. Cancer Research 1990; 50: 5720–5726
   PubMedGoogle Scholar
• Le Blanc G. A., Suxsdeth S. S., Weber G. F., Waxman D. J. Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats. Cancer Research 1990; 52: 540–547
   Google Scholar
• Marinello A. J., Gurtoo H. L., Struck R. F., Paul B. Denaturation of cytochrome P-450 by cyclophosphamide metabolites. Biochemical and Biophysical Research Communications 1978; 4: 1347–1353
   Google Scholar
• Marinello A. J., Bansal S. K., Paul B., Koser P. L., Love J., Struck R. F., Gurtoo H. L. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Cancer Research 1989; 44: 4615–4621
   Google Scholar
• McClure M. T., Stupans I. Investigation of the mechanism by which cyclophosphamide alters cytochrome P450 in male rats. Biochemical Pharmacology 1992; 43: 2655–2658
   PubMed Web of Science ®Google Scholar
• McClure M. T., Stupans I. Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamide. Biochemical Pharmacology 1995; 49: 1827–1836
   PubMed Web of Science ®Google Scholar
• McManus M. E., De La Hall P. M., Stupans I., Brennan J., Burgess W., Robson R., Birkett D. J. Immunohistochemical localisation and quantitation of NADPH-cytochrome P-450 reductase in human liver. Molecular Pharmacology 1987; 32: 189–194
   PubMedGoogle Scholar
• Miwa G. T., Cho A. K. Stimulation of microsomal N-demethylation by solubilised NADPH-cytochrome c reductase. LifeS ciences 1976; 18: 983–988
   PubMedGoogle Scholar
• Newell D. R., Gore M. E. Toxicity of alkylating agents: clinical characteristics and pharmacokinetic determinants. Toxicity and Anticancer Drugs, G. Powis, M. P. Hacker. Pergamon, New York 1991; 44–62
   Google Scholar
• Patel J. M., Ortiz E., Kolmstetter C., Leibman K. C. Selective inactivation of rat lung and liver microsomal NADPH-cytochrome c reductase by acrolein. Drug Metabolism and Disposition 1984; 12: 460–463
   PubMedGoogle Scholar
• Patel J. M. Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicology 1987; 45: 79–91
   PubMed Web of Science ®Google Scholar
• Patel J. M. Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacology and Therapeutics 1990; 47: 137–146
   PubMed Web of Science ®Google Scholar
• Ram P. A., Waxman D. J. Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Molecular Endocrinology 1991; 5: 13–20
   PubMedGoogle Scholar
• Ram P. A., Waxman D. J. Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms. Journal of Biological Chemistry 1992; 267: 3294–3301
   PubMed Web of Science ®Google Scholar
• Rizzardini M., Ferraroli A., Dal Fiume D., Cantoni L. Cyclophosphamide-impaired regulation of hepatic heme metabolism. Experimentia 1984; 40: 1390–1391
   PubMedGoogle Scholar
• Schuetz E. G., Wrighton S. A., Barwick J. L., Guzelian P. S. Induction of cytochrome P-450 by glucocorticoids in rat liver. I. Evidence that glucocorticoids and pregnenolone 16α-carbonitrile regulate de novo synthesis of a common form of cytochrome P-450 in cultures of adult rat hepatocytes and in the liver. in vivo. Journal of Biological Chemistry 1984; 259: 1999–2006
   PubMed Web of Science ®Google Scholar
• Simmons D. L., McUiddy P., Kaspar C. B. Induction of hepatic mixed-function oxidase system by synthetic glucocorticoids; transcriptional and post-transcriptional regulation. Journal of Biological Chemistry 1987; 262: 326–332
   PubMed Web of Science ®Google Scholar
• Smith R. D., Kehrer J. P. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. Cancer Research 1991; 51: 542–548
   PubMed Web of Science ®Google Scholar
• Stupans I., Sansom L. N. The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin. Biochemical Pharmacology 1991; 42: 2085–2090
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W., Veronese M. E., Birkett D. J., Miners J. O. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochemical Pharmacology 1993; 46: 1975–1981
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Regulation of liver-specific steroid metabolizing cytochromes P450: cholesterol 7α-hydroxylase, bile acid 6β-hydroxylase, and growth hormone-responsive steroid hormone hydroxylases. Journal of Steroidal Biochemistry and Molecular Biology 1992; 43: 1055–1072
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalysed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry 1983; 258: 11937–11947
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Morissey J. J., Le Blanc G. A. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: Pituitary control of hepatic cytochrome P-450 reductase. Molecular Pharmacology 1989; 35: 519–525
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos P. G., Mode A., Norstedt G., Gustafsson J. A. Regulation of sexual differentiation in drug and steroid metabolism. Trends in the Pharmacological Sciences 1989; 10: 149–153
   PubMed Web of Science ®Google Scholar